Company intelligence / Profile preview
Simcere
Nanjing, Jiangsu, Chinasimcere.com ↗
- Ownership
- Private
- Employees
- ~5200
- Development stage
- Other
01
Overview
Simcere is a leading Chinese pharmaceutical company with strong R&D capabilities focused on oncology, CNS disorders, and autoimmune diseases. It has over 60 innovative drug programs spanning monoclonal antibodies to small molecules. The company has several drugs approved in China and an extensive late-stage pipeline including NDAs filed for new molecular entities. Its innovation arm ("Zaiming") is advancing first-in-class multispecific antibodies and ADCs into global clinical trials.
- Therapeutic areas
- ImmunologyEndocrinologyOncology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyMulti-specific antibodyFusion proteinAntibody-drug conjugateSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
AbbVie partnership on trispecific/multispecific antibodiesMultiple collaborations with multinational pharma companiesAcademic partnerships via Scientific Advisory Board
Beyond the preview
Go deeper on Simcere.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Simcere.